News
FDA declines to approve AbbVie's Botox follow-up
AbbVie's bid to bring a rapid and shorter-acting botulinum toxin product to the US market has been knocked back by the FDA.
News
FDA clears first genetic hearing loss gene therapy
Regeneron's Otarmeni is the first gene therapy for congenital hearing loss to be cleared by the FDA, and will be made available for free in the US.
News
Trump's DOJ reschedules medicinal marijuana, increasing acce...
The US Justice Department has issued an order moving medical marijuana to Schedule III, removing some barriers to access for patients and researchers.
Market Access
Fighting fake GLP-1s to protect patients & preserve trust
Counterfeit drug promotion is a patient safety, brand equity, and public trust issue.
News
AbbVie makes record investment in North Carolina plant
AbbVie's $100bn programme of facility investments in the US has continued with a new 185-acre campus in Durham, North Carolina.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
